Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1953 2
1954 5
1955 4
1957 11
1958 8
1959 11
1960 19
1961 14
1962 11
1964 2
1965 27
1966 54
1967 60
1968 53
1969 65
1970 78
1971 65
1972 88
1973 68
1974 91
1975 101
1976 85
1977 102
1978 110
1979 115
1980 106
1981 101
1982 125
1983 197
1984 207
1985 236
1986 255
1987 232
1988 348
1989 440
1990 379
1991 397
1992 465
1993 501
1994 544
1995 553
1996 572
1997 551
1998 701
1999 679
2000 803
2001 942
2002 1009
2003 1084
2004 1125
2005 1287
2006 1292
2007 1537
2008 1829
2009 1786
2010 2063
2011 2148
2012 2528
2013 2666
2014 2884
2015 2860
2016 2705
2017 2667
2018 2625
2019 1411
2020 26
Text availability
Article attribute
Article type
Publication date

Search Results

42,165 results
Results by year
Filters applied: . Clear all
Page 1
Hepatocellular carcinoma: From diagnosis to treatment
Grandhi MS, et al. Surg Oncol 2016 - Review. PMID 27312032
Primary liver cancer is the sixth most common cancer overall and the second most common cause of cancer mortality worldwide. ...
Primary liver cancer is the sixth most common cancer overall and the second most common cause of cancer mortality worldwide. ...
Hepatocellular carcinoma
El-Serag HB. N Engl J Med 2011 - Review. PMID 21992124
Liver-directed therapy for hepatocellular carcinoma.
Narsinh KH, et al. Abdom Radiol (NY) 2018 - Review. PMID 29230556
Liver-directed therapy is a critical component of treatment strategies for hepatocellular carcinoma. These therapies included percutaneous image-guided ablation, transarterial chemoembolization, and transarterial radioembolization, and are administered by interventional radiologists. ...This article seeks to review the various liver-directed treatment modalities for treatment of hepatocellular carcinoma, with attention to their efficacy and patient selection criteria....
Liver-directed therapy is a critical component of treatment strategies for hepatocellular carcinoma. These therapies included percuta
Treatment of Liver Cancer.
Liu CY, et al. Cold Spring Harb Perspect Med 2015 - Review. PMID 26187874 Free PMC article.
Primary liver cancer, mostly hepatocellular carcinoma, remains a difficult-to-treat cancer. Incidence of liver cancer varies geographically and parallels with the geographic prevalence of viral hepatitis. ...This work focuses on reviewing the incidence, staging, and treatment of liver cancer....
Primary liver cancer, mostly hepatocellular carcinoma, remains a difficult-to-treat cancer. Incidence of liver cancer varies g …
Treatment Strategies for Hepatocellular Carcinoma ⁻ a Multidisciplinary Approach
Lurje I, et al. Int J Mol Sci 2019 - Review. PMID 30909504 Free PMC article.
While orthotopic liver transplantation (OLT) and surgical resection are the only two curative treatment options, OLT remains the best treatment strategy as it not only removes the tumor but cures the underlying liver disease. As the applicability of OLT is nowadays limited by organ shortage, major liver resections ⁻ even in patients with underlying chronic liver disease ⁻ are adopted increasingly into clinical practice. ...
While orthotopic liver transplantation (OLT) and surgical resection are the only two curative treatment options, OLT remains the best …
Management of fibrolamellar hepatocellular carcinoma
Chaudhari VA, et al. Chin Clin Oncol 2018 - Review. PMID 30395718 Free article.
Fibrolamellar hepatocellular carcinoma (FLHCC) is a primary liver tumor. It is a pathologically distinct variety of hepatocellular carcinoma (HCC). ...Surgery (resection/liver transplantation) is the current mainstay of treatment and remains the only potentially curative option. ...
Fibrolamellar hepatocellular carcinoma (FLHCC) is a primary liver tumor. It is a pathologically distinct variety of hepatocellular ca …
Challenges of advanced hepatocellular carcinoma
Colagrande S, et al. World J Gastroenterol 2016 - Review. PMID 27678348 Free PMC article.
The management of patients with HCC is complex, as both the tumour stage and any underlying liver disease must be considered conjointly. ...Specifics such as dose limiting toxicity and safety profile in patients with liver dysfunction related to the underlying chronic liver disease should be considered when developing therapies in HCC. ...
The management of patients with HCC is complex, as both the tumour stage and any underlying liver disease must be considered conjoint …
42,165 results
Jump to page
Feedback